Business Issues/Benchmarks: Page 383

Cannabis Business Insurance: Compliance vs. Properly Protecting Your Business

Cannabis businesses should understand their areas of exposure and consider purchasing additional coverage on top of state and local requirements.

Mergers and Acquisitions 101: Cannabis Market Trends and What Consolidation Means for the Global Industry

Dan Nicholls, director of Capital Markets Advisory Services at ELLO, discusses the past year of high-profile acquisition deals and looks ahead to 2019.

Cresco Labs Acquires Assets in Massachusetts With First Harvest Planned for Spring 2019

The company is acquiring 100 percent of Hope Heal Health Inc. and an affiliated real estate entity.

Behind the Scenes Accounting Firm Helps Cannabis Companies Go Public

Adnant, a small accounting and consulting firm, went after opportunity in the cannabis industry in 2009.

Sproutly Announces Hiring of Former Executive From SC Johnson and Pepsi

Melise Panetta is joining the senior leadership team as vice president of sales and marketing.

Ohio Awards Additional Medical Marijuana Cultivation License to Ohio Grown Therapies

The Johnstown company demonstrated at an administrative hearing that its application should have received additional points for its pesticide plan.

Aphria Shares Tumble a Second Day as Cannabis Firm Defends Deals

The Canadian cannabis producer is fighting back against short sellers.

Sequoia Labs Voluntarily Surrenders Testing License After State Inspection Finds Falsified Reports

Due to a ‘faulty instrument,’ the California testing lab was only testing for 44 of the required 66 pesticides.

CNBC: Marlboro Maker Altria in Talks to Buy Cannabis Company Cronos Group

Cronos has not agreed to any deal and there is no certainty it will do so.

MJardin Group Announces Investment in DNA Genetics

MJardin’s investment was part of a $35 million financing completed by DNA Genetics last week.

Cresco Labs Begins Trading on the Canadian Securities Exchange Under Ticker Symbol 'CL'

A new investors website launched at investors.crescolabs.com.

FSD Pharma Achieves Over 4 Billion Shares Traded in First 6 Months

The company has traded over four billion Class B subordinate voting shares in its first six months of trading on the Canadian Securities Exchange.

Previous Page

Page 383 of 518

Next Page